Meet the Speakers: Julie Beynon on Advertising Assessment
Who is Julie Beynon?
Julie Beynon is one of the medical assessors at the Medicines and Healthcare products Regulatory Agency (MHRA) whose work sits at the intersection of clinical science and commercial communication. Her remit covers diabetes medicines and the promotional materials that accompany them, a combination that places her at the heart of decisions about how therapies are presented to healthcare professionals and patients.

At the MHRA Advertising Seminar she will share practical insight into how advertising assessment works in this therapeutic area, drawing on day to day experience of reviewing claims, imagery and supporting evidence.
Why diabetes materials need specialist review
Diabetes is a long term condition affecting millions of people in the UK, and the medicines used to manage it range from established treatments to newer agents with complex mechanisms. Promotional material in this field must be accurate, balanced and consistent with the licence, because small errors can influence prescribing decisions with real clinical consequences.
Assessors like Julie look closely at efficacy claims, safety information, comparisons between products and the way trial data are summarised. Her sessions will illustrate how these judgements are made in practice rather than in theory.
Good advertising assessment is not about catching people out; it is about making sure the information prescribers see is trustworthy.
How advertising assessment works
The MHRA reviews promotional materials against the requirements of the Human Medicines Regulations and the industry codes that sit alongside them. Assessors check that claims are substantiated, that mandatory information is present and that the overall impression is not misleading.
- Receipt and triage of the material submitted for review.
- Detailed examination of claims against the licensed indications.
- Verification of references and supporting data.
- Consideration of balance, prominence and overall impression.
- Feedback, and where necessary, a request for amendment or withdrawal.
Julie will walk through these stages using examples drawn from diabetes promotion, showing where companies most often fall short and how early engagement can prevent problems.
What delegates will take away
Attendees can expect a clear picture of the standards applied to diabetes advertising and a better understanding of how to prepare materials that meet them. The session is designed for regulatory affairs professionals, medical writers, marketing teams and anyone involved in sign off.
- An overview of the assessor role within the MHRA.
- Common pitfalls in diabetes promotional claims.
- The importance of balanced safety messaging.
- Practical tips for smoother assessment outcomes.
Meet the speakers at the seminar
The MHRA Advertising Seminar brings together assessors, industry specialists and legal experts to discuss the realities of advertising review. Julie Beynon's contribution offers a rare, direct view of how one therapeutic area is handled from the inside.
Places are limited, so delegates are encouraged to register early and to bring their questions about diabetes promotion and advertising assessment.
